China
· Delayed Price · Currency is CNY Hybio Pharmaceutical Statistics
Total Valuation
SHE:300199 has a market cap or net worth of CNY 14.35 billion. The enterprise value is 16.09 billion.
| Market Cap | 14.35B |
| Enterprise Value | 16.09B |
Important Dates
The next estimated earnings date is Thursday, August 21, 2025.
| Earnings Date | Aug 21, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
SHE:300199 has 883.24 million shares outstanding. The number of shares has increased by 9.72% in one year.
| Current Share Class | 883.24M |
| Shares Outstanding | 883.24M |
| Shares Change (YoY) | +9.72% |
| Shares Change (QoQ) | +1.24% |
| Owned by Insiders (%) | 24.70% |
| Owned by Institutions (%) | 3.62% |
| Float | 640.91M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 19.14 |
| PB Ratio | 21.54 |
| P/TBV Ratio | 39.66 |
| P/FCF Ratio | 248.51 |
| P/OCF Ratio | 75.55 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 85.06, with an EV/FCF ratio of 278.56.
| EV / Earnings | -179.39 |
| EV / Sales | 21.45 |
| EV / EBITDA | 85.06 |
| EV / EBIT | n/a |
| EV / FCF | 278.56 |
Financial Position
The company has a current ratio of 0.31, with a Debt / Equity ratio of 2.67.
| Current Ratio | 0.31 |
| Quick Ratio | 0.15 |
| Debt / Equity | 2.67 |
| Debt / EBITDA | 9.40 |
| Debt / FCF | 30.77 |
| Interest Coverage | 0.41 |
Financial Efficiency
Return on equity (ROE) is -13.37% and return on invested capital (ROIC) is 1.09%.
| Return on Equity (ROE) | -13.37% |
| Return on Assets (ROA) | 0.89% |
| Return on Invested Capital (ROIC) | 1.09% |
| Return on Capital Employed (ROCE) | 2.98% |
| Revenue Per Employee | 724,553 |
| Profits Per Employee | -86,651 |
| Employee Count | 1,035 |
| Asset Turnover | 0.25 |
| Inventory Turnover | 1.86 |
Taxes
In the past 12 months, SHE:300199 has paid 19.84 million in taxes.
| Income Tax | 19.84M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +42.51% in the last 52 weeks. The beta is 1.08, so SHE:300199's price volatility has been similar to the market average.
| Beta (5Y) | 1.08 |
| 52-Week Price Change | +42.51% |
| 50-Day Moving Average | 14.94 |
| 200-Day Moving Average | 12.81 |
| Relative Strength Index (RSI) | 53.33 |
| Average Volume (20 Days) | 96,891,232 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHE:300199 had revenue of CNY 749.91 million and -89.68 million in losses. Loss per share was -0.10.
| Revenue | 749.91M |
| Gross Profit | 399.75M |
| Operating Income | 43.09M |
| Pretax Income | -76.47M |
| Net Income | -89.68M |
| EBITDA | 188.31M |
| EBIT | 43.09M |
| Loss Per Share | -0.10 |
Balance Sheet
The company has 59.54 million in cash and 1.78 billion in debt, giving a net cash position of -1.72 billion or -1.94 per share.
| Cash & Cash Equivalents | 59.54M |
| Total Debt | 1.78B |
| Net Cash | -1.72B |
| Net Cash Per Share | -1.94 |
| Equity (Book Value) | 666.39M |
| Book Value Per Share | 0.73 |
| Working Capital | -1.10B |
Cash Flow
In the last 12 months, operating cash flow was 189.98 million and capital expenditures -132.22 million, giving a free cash flow of 57.76 million.
| Operating Cash Flow | 189.98M |
| Capital Expenditures | -132.22M |
| Free Cash Flow | 57.76M |
| FCF Per Share | 0.07 |
Margins
Gross margin is 53.31%, with operating and profit margins of 5.75% and -11.96%.
| Gross Margin | 53.31% |
| Operating Margin | 5.75% |
| Pretax Margin | -10.20% |
| Profit Margin | -11.96% |
| EBITDA Margin | 25.11% |
| EBIT Margin | 5.75% |
| FCF Margin | 7.70% |
Dividends & Yields
SHE:300199 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -9.72% |
| Shareholder Yield | n/a |
| Earnings Yield | -0.62% |
| FCF Yield | 0.40% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on April 14, 2015. It was a forward split with a ratio of 2.
| Last Split Date | Apr 14, 2015 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
SHE:300199 has an Altman Z-Score of 1.64 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.64 |
| Piotroski F-Score | 6 |